Dramatic reduction in primary endpoint with precision testing in stable patients with suspected CAD

3' education - Nov. 7, 2022 - Prof. Pamela Douglas, MD - Durham, NC, USA

Educational information

This video was recorded during the American Heart Association’s Scientific Sessions 2022 in Chicago, IL, USA.

Faculty

Pamela S Douglas MD is the Ursula Geller Professor of Research in Cardiovascular Diseases in the Department of Medicine at Duke University and Director of the Multimodality Imaging Program at Duke Clinical Research Institute, Durham, NC, USA.

Disclosures

This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

Read our summary of the PRECISE trial

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.